{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:04:58Z","timestamp":1783764298227,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40257-020-00568-2","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T05:06:34Z","timestamp":1605157594000},"page":"267-274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Isotretinoin and Risk of Cardiovascular Events in Adults with Acne: A\u00a0Population-based Retrospective Cohort Study"],"prefix":"10.1007","volume":"22","author":[{"given":"Serena","family":"Ghanshani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Sum","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"issue":"3","key":"568_CR1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/bjd.12149","volume":"168","author":"K Bhate","year":"2013","unstructured":"Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168(3):474\u201385.","journal-title":"Br J Dermatol."},{"issue":"5","key":"568_CR2","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","volume":"74","author":"AL Zaenglein","year":"2016","unstructured":"Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-73.e33.","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"568_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1067\/mjd.2002.120529","volume":"46","author":"DK Wysowski","year":"2002","unstructured":"Wysowski DK, Swann J, Vega A. Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000. J Am Acad Dermatol. 2002;46(4):505\u20139.","journal-title":"J Am Acad Dermatol."},{"issue":"6","key":"568_CR4","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1111\/j.1365-2133.2010.10060.x","volume":"163","author":"EJ McGrath","year":"2010","unstructured":"McGrath EJ, Lovell CR, Gillison F, Darvay A, Hickey JR, Skevington SM. A prospective trial of the effects of isotretinoin on quality of life and depressive symptoms. Br J Dermatol. 2010;163(6):1323\u20139.","journal-title":"Br J Dermatol."},{"issue":"9","key":"568_CR5","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/ijd.13950","volume":"57","author":"T Kovitwanichkanont","year":"2018","unstructured":"Kovitwanichkanont T, Driscoll T. A comparative review of the isotretinoin pregnancy risk management programs across four continents. Int J Dermatol. 2018;57(9):1035\u201346.","journal-title":"Int J Dermatol."},{"issue":"8","key":"568_CR6","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/archderm.142.8.1016","volume":"142","author":"LT Zane","year":"2006","unstructured":"Zane LT, Leyden WA, Marqueling AL, Manos MM. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris. Arch Dermatol. 2006;142(8):1016\u201322.","journal-title":"Arch Dermatol."},{"issue":"9","key":"568_CR7","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/ajg.2010.124","volume":"105","author":"SD Crockett","year":"2010","unstructured":"Crockett SD, Porter CQ, Martin CF, Sandler RS, Kappelman MD. Isotretinoin use and the risk of inflammatory bowel disease: a case-control study. Am J Gastroenterol. 2010;105(9):1986\u201393.","journal-title":"Am J Gastroenterol."},{"issue":"10","key":"568_CR8","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1001\/jamadermatol.2019.1416","volume":"155","author":"S Singer","year":"2019","unstructured":"Singer S, Tkachenko E, Sharma P, Barbieri JS, Mostaghimi A. Psychiatric adverse events in patients taking isotretinoin as reported in a food and drug administration database from 1997 to 2017. JAMA Dermatol. 2019;155(10):1162\u20136.","journal-title":"JAMA Dermatol."},{"issue":"3","key":"568_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0190-9622(88)70078-X","volume":"18","author":"M Bigby","year":"1988","unstructured":"Bigby M, Stern RS. Adverse reactions to isotretinoin. A report from the adverse drug reaction reporting system. J Am Acad Dermatol. 1988;18(3):543\u201352.","journal-title":"J Am Acad Dermatol."},{"issue":"6","key":"568_CR10","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1590\/abd1806-4841.20165138","volume":"91","author":"S Alan","year":"2016","unstructured":"Alan S, Unal B, Yildirim A. Premature ventricular contractions associated with isotretinoin use. An Bras Dermatol. 2016;91(6):820\u20131.","journal-title":"An Bras Dermatol."},{"issue":"2","key":"568_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5152\/akd.2015.5790","volume":"15","author":"E Guler","year":"2015","unstructured":"Guler E, Babur Guler G, Yavuz C, Kizilirmak F. An unknown side effect of isotretinoin: pericardial effusion with atrial tachycardia. Anatol J Cardiol. 2015;15(2):168\u20139.","journal-title":"Anatol J Cardiol."},{"issue":"3","key":"568_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1046\/j.1365-2133.2003.05209_1.x","volume":"148","author":"K Charalabopoulos","year":"2003","unstructured":"Charalabopoulos K, Papalimneou V, Charalabopoulos A, Hatzis J. Two new adverse effects of isotretinoin. Br J Dermatol. 2003;148(3):593.","journal-title":"Br J Dermatol."},{"issue":"4","key":"568_CR13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1540-8159.2005.09365.x","volume":"28","author":"C Hasdemir","year":"2005","unstructured":"Hasdemir C, Sagcan A, Sekuri C, Ildizli M, Ulucan C, Ceylan C. Isotretinoin (13-cis-retinoic acid) associated atrial tachycardia. Pacing Clin Electrophysiol. 2005;28(4):348\u20139.","journal-title":"Pacing Clin Electrophysiol."},{"key":"568_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijcard.2014.11.169","volume":"181","author":"N Lorenzo","year":"2015","unstructured":"Lorenzo N, Antuna P, Dominguez L, Rivero F, Bastante T, Alfonso F. Acute myocardial infarction in a young woman on isotretinoin treatment. Int J Cardiol. 2015;181:39\u201341.","journal-title":"Int J Cardiol."},{"issue":"4","key":"568_CR15","first-page":"324","volume":"47","author":"M Akcay","year":"2019","unstructured":"Akcay M, Yuksel S. Isotretinoin-associated possible Kounis syndrome: a case report and a review of other cardiovascular side effects reported in the literature. Turk Kardiyol Dern Ars. 2019;47(4):324\u20138.","journal-title":"Turk Kardiyol Dern Ars."},{"issue":"3","key":"568_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1177\/1077558712466293","volume":"70","author":"SF Derose","year":"2013","unstructured":"Derose SF, Contreras R, Coleman KJ, Koebnick C, Jacobsen SJ. Race and ethnicity data quality and imputation using U.S. Census data in an integrated health system: the Kaiser Permanente Southern California experience. Med Care Res Rev. 2013;70(3):330\u201345.","journal-title":"Med Care Res Rev."},{"issue":"5","key":"568_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1684\/ejd.2015.2606","volume":"25","author":"A Ejaz","year":"2015","unstructured":"Ejaz A, Malaiyandi V, Kim WB, Rogalska T, Alhusayen R. Validating the diagnostic code for acne in a tertiary care dermatology centre. Eur J Dermatol. 2015;25(5):469\u201371.","journal-title":"Eur J Dermatol."},{"issue":"1","key":"568_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8\u201327.","journal-title":"Med Care."},{"issue":"3","key":"568_CR19","first-page":"147","volume":"56","author":"U Ventura","year":"1971","unstructured":"Ventura U, Ceriani T, Zelaschi F, Rindi G. Action potential modifications in rat myocardial cells induced by hypervitaminosis A. Q J Exp Physiol Cogn Med Sci. 1971;56(3):147\u201355.","journal-title":"Q J Exp Physiol Cogn Med Sci."},{"issue":"2","key":"568_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-4632.2008.03341.x","volume":"47","author":"Y Selcoki","year":"2008","unstructured":"Selcoki Y, Gorpelioglu C, Turgut F, Sarifakioglu E, Ozkara A, Tekin O, et al. Isotretinoin: is there any arrhythmic effect? Int J Dermatol. 2008;47(2):195\u20137.","journal-title":"Int J Dermatol."},{"issue":"7","key":"568_CR21","first-page":"710","volume":"10","author":"R Dursun","year":"2011","unstructured":"Dursun R, Alpaslan M, Caliskan M, Ciftci O, Kulaksizoglu S, Seckin D, et al. Isotretinoin does not prolong QT intervals and QT dispersion in patients with severe acne: a surprising finding for a drug with numerous side effects. J Drugs Dermatol. 2011;10(7):710\u20134.","journal-title":"J Drugs Dermatol."},{"issue":"1","key":"568_CR22","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1111\/jdv.15886","volume":"34","author":"TY Tsai","year":"2020","unstructured":"Tsai TY, Hsieh TS, Yang TH, Wang HH, Lin RL, Huang YC. The effects of isotretinoin therapy on serum homocysteine, folate and vitamin B12 levels in patients with acne: a meta-analysis and meta-regression. J Eur Acad Dermatol Venereol. 2020;34(1):e32\u20134.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"4","key":"568_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/09546630701846079","volume":"19","author":"M Polat","year":"2008","unstructured":"Polat M, Lenk N, Bingol S, Oztas P, Ilhan MN, Artuz F, et al. Plasma homocysteine level is elevated in patients on isotretinoin therapy for cystic acne: a prospective controlled study. J Dermatol Treat. 2008;19(4):229\u201332.","journal-title":"J Dermatol Treat."},{"issue":"2","key":"568_CR24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MCA.0000000000000800","volume":"31","author":"LS Rallidis","year":"2020","unstructured":"Rallidis LS, Kosmas N, Rallidi T, Pavlakis G, Kiouri E, Zolindaki M. Homocysteine is an independent predictor of long-term cardiac mortality in patients with stable coronary artery disease in the era of statins. Coron Artery Dis. 2020;31(2):152\u20136.","journal-title":"Coron Artery Dis."},{"issue":"2","key":"568_CR25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.thromres.2014.05.025","volume":"134","author":"A Schaffer","year":"2014","unstructured":"Schaffer A, Verdoia M, Cassetti E, Marino P, Suryapranata H, De Luca G, et al. Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study. Thromb Res. 2014;134(2):288\u201393.","journal-title":"Thromb Res."},{"issue":"1","key":"568_CR26","first-page":"238","volume":"49","author":"G Soyuduru","year":"2019","unstructured":"Soyuduru G, Osoy Adisen E, Kadioglu Ozer I, Aksakal AB. The effect of isotretinoin on insulin resistance and adipocytokine levels in acne vulgaris patients. Turk J Med Sci. 2019;49(1):238\u201344.","journal-title":"Turk J Med Sci."},{"issue":"12","key":"568_CR27","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.2337\/db18-0449","volume":"67","author":"T Jelenik","year":"2018","unstructured":"Jelenik T, Flogel U, Alvarez-Hernandez E, Scheiber D, Zweck E, Ding Z, et al. Insulin resistance and vulnerability to cardiac ischemia. Diabetes. 2018;67(12):2695\u2013702.","journal-title":"Diabetes"},{"issue":"1","key":"568_CR28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijcard.2011.05.048","volume":"163","author":"EA Soriano","year":"2013","unstructured":"Soriano EA, Azevedo PS, Miot HA, Minicucci MF, Pansani MC, Matsubara LS, et al. Cardiac remodeling induced by 13-cis retinoic acid treatment in acne patients. Int J Cardiol. 2013;163(1):68\u201371.","journal-title":"Int J Cardiol."},{"issue":"13","key":"568_CR29","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1001\/jama.247.13.1800","volume":"247","author":"C Macek","year":"1982","unstructured":"Macek C. Synthetic vitamin A analogue (isotretinoin) awaiting approval for cystic acne therapy. JAMA. 1982;247(13):1800\u20131.","journal-title":"JAMA"},{"issue":"16","key":"568_CR30","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJM198510173131604","volume":"313","author":"S Bershad","year":"1985","unstructured":"Bershad S, Rubinstein A, Paterniti JR, Le NA, Poliak SC, Heller B, et al. Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N Engl J Med. 1985;313(16):981\u20135.","journal-title":"N Engl J Med."},{"issue":"7","key":"568_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrcardio.2017.31","volume":"14","author":"Z Reiner","year":"2017","unstructured":"Reiner Z. Hypertriglyceridaemia and risk of coronary artery disease. Nat Rev Cardiol. 2017;14(7):401\u201311.","journal-title":"Nat Rev Cardiol."},{"issue":"8","key":"568_CR32","doi-asserted-by":"publisher","first-page":"582","DOI":"10.7326\/0003-4819-136-8-200204160-00007","volume":"136","author":"N Rodondi","year":"2002","unstructured":"Rodondi N, Darioli R, Ramelet AA, Hohl D, Lenain V, Perdrix J, et al. High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study. Ann Intern Med. 2002;136(8):582\u20139.","journal-title":"Ann Intern Med."},{"issue":"1","key":"568_CR33","first-page":"14","volume":"20","author":"A Saklamaz","year":"2016","unstructured":"Saklamaz A, Uyar B, Yalcin M, Cengiz H. Isotretinoin increased carotid intima-media thickness in acne patients. Hippokratia. 2016;20(1):14\u20138.","journal-title":"Hippokratia."},{"issue":"1","key":"568_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000330326","volume":"223","author":"A Berard","year":"2011","unstructured":"Berard A, Azoulay L, Nakhai-Pour HR, Moussally K. Isotretinoin and the risk of cardiovascular, cerebrovascular and thromboembolic disorders. Dermatology. 2011;223(1):45\u201351.","journal-title":"Dermatology"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-020-00568-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-020-00568-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-020-00568-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T06:18:37Z","timestamp":1616048317000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-020-00568-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["568"],"URL":"https:\/\/doi.org\/10.1007\/s40257-020-00568-2","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]},"assertion":[{"value":"12 November 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for the conduct of this study or the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Serena Ghanshani, Cheng Chen, Bryan Lin, Hui Zhou, and Ming-Sum Lee have no conflicts of interest that are directly relevant to the contents of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the KPSC Institutional Review Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable. A waiver of informed consent was obtained because of the observational nature of the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The data that support the findings of this study may be made available from Kaiser Permanente Southern California (). Restrictions apply to the availability of these data.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"Codes may be made available from Kaiser Permanente Southern California ().","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"M-SL and BL had full access to all the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis. M-SL, SG, CC, BL, and HZ were involved in the study concept and design, and critical revision of the manuscript for important intellectual content. M-SL, SG, and BL were responsible for the acquisition of data, and analysis and interpretation of the data. M-SL and BL were involved in statistical analysis. SG and M-SL were responsible for drafting of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}